These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 8473379

  • 1. Growth hormone induces insulin resistance in Laron dwarf cells via lactogenic receptors.
    Geffner ME, Bersch N, Golde DW.
    J Clin Endocrinol Metab; 1993 Apr; 76(4):1039-47. PubMed ID: 8473379
    [Abstract] [Full Text] [Related]

  • 2. T-lymphoblast cell lines from Laron dwarfs augment basal colony formation in response to extremely high concentrations of growth hormone.
    Geffner ME, Bersch N, Lippe BM, Golde DW.
    J Clin Endocrinol Metab; 1990 Mar; 70(3):810-3. PubMed ID: 2307733
    [Abstract] [Full Text] [Related]

  • 3. Tissues of the Laron dwarf are sensitive to insulin-like growth factor I but not to growth hormone.
    Geffner ME, Golde DW, Lippe BM, Kaplan SA, Bersch N, Li CH.
    J Clin Endocrinol Metab; 1987 May; 64(5):1042-6. PubMed ID: 3031118
    [Abstract] [Full Text] [Related]

  • 4. Growth hormone mediates the growth of T-lymphoblast cell lines via locally generated insulin-like growth factor-I.
    Geffner ME, Bersch N, Lippe BM, Rosenfeld RG, Hintz RL, Golde DW.
    J Clin Endocrinol Metab; 1990 Aug; 71(2):464-9. PubMed ID: 2380340
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome.
    Vaccarello MA, Diamond FB, Guevara-Aguirre J, Rosenbloom AL, Fielder PJ, Gargosky S, Cohen P, Wilson K, Rosenfeld RG.
    J Clin Endocrinol Metab; 1993 Jul; 77(1):273-80. PubMed ID: 7686916
    [Abstract] [Full Text] [Related]

  • 11. Characterization of insulin, insulin-like growth factors I and II, and growth hormone receptors on human leukemic lymphoblasts.
    Lee PD, Rosenfeld RG, Hintz RL, Smith SD.
    J Clin Endocrinol Metab; 1986 Jan; 62(1):28-35. PubMed ID: 2999181
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I.
    Fleenor D, Arumugam R, Freemark M.
    Horm Res; 2006 Jan; 66(3):101-10. PubMed ID: 16735796
    [Abstract] [Full Text] [Related]

  • 14. Growth responses in a mutant dwarf rat to human growth hormone and recombinant human insulin-like growth factor I.
    Skottner A, Clark RG, Fryklund L, Robinson IC.
    Endocrinology; 1989 May; 124(5):2519-26. PubMed ID: 2707163
    [Abstract] [Full Text] [Related]

  • 15. Absence of the plasma growth hormone-binding protein in Laron-type dwarfism.
    Baumann G, Shaw MA, Winter RJ.
    J Clin Endocrinol Metab; 1987 Oct; 65(4):814-6. PubMed ID: 3654924
    [Abstract] [Full Text] [Related]

  • 16. Effects of sex and pregnancy hormones on growth hormone and prolactin receptor gene expression in insulin-producing cells.
    Møldrup A, Petersen ED, Nielsen JH.
    Endocrinology; 1993 Sep; 133(3):1165-72. PubMed ID: 8365359
    [Abstract] [Full Text] [Related]

  • 17. Growth hormone is a human macrophage activating factor. Priming of human monocytes for enhanced release of H2O2.
    Warwick-Davies J, Lowrie DB, Cole PJ.
    J Immunol; 1995 Feb 15; 154(4):1909-18. PubMed ID: 7836772
    [Abstract] [Full Text] [Related]

  • 18. Laron-type dwarfism with apparently normal high affinity serum growth hormone-binding protein.
    Buchanan CR, Maheshwari HG, Norman MR, Morrell DJ, Preece MA.
    Clin Endocrinol (Oxf); 1991 Aug 15; 35(2):179-85. PubMed ID: 1934534
    [Abstract] [Full Text] [Related]

  • 19. Growth hormone induces resistance to the mitogenic action of insulin through local IGF-I. Studies in normal and Pygmy T-cell lines.
    Geffner ME, Bersch N, Bailey RC, Golde DW.
    Diabetes; 1994 Jan 15; 43(1):68-72. PubMed ID: 8262319
    [Abstract] [Full Text] [Related]

  • 20. Different effects of intermittent and continuous growth hormone (GH) administration on serum somatomedin-C/insulin-like growth factor I and liver GH receptors in hypophysectomized rats.
    Maiter D, Underwood LE, Maes M, Davenport ML, Ketelslegers JM.
    Endocrinology; 1988 Aug 15; 123(2):1053-9. PubMed ID: 3396497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.